(Q43722064)

26 November 2017

Glatiramer acetate (GA) induces IL-13/IL-5 secretion in naive T cells (English)

1 reference

26 November 2017

Wiesemann E

1

1 reference

26 November 2017

Klatt J

2

1 reference

26 November 2017

Sönmez D

3

1 reference

26 November 2017

Blasczyk R

4

1 reference

26 November 2017

Heidenreich F

5

1 reference

26 November 2017

Windhagen A

6

1 reference

26 November 2017

1 September 2001

1 reference

Journal of Neuroimmunology

26 November 2017

1 reference

26 November 2017

119

1 reference

26 November 2017

137-144

1 reference

26 November 2017

1

1 reference

Copolymer 1 acts against the immunodominant epitope 82-100 of myelin basic protein by T cell receptor antagonism in addition to major histocompatibility complex blocking

26 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900379-4

7 January 2021

Specific Th2 cells accumulate in the central nervous system of mice protected against experimental autoimmune encephalomyelitis by copolymer 1

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900379-4

7 January 2021

A pilot trial of Cop 1 in exacerbating-remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900379-4

7 January 2021

Immunogenic potentials of copolymer I in normal human lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900379-4

7 January 2021

Glatiramer acetate (copolymer-1)-specific, human T cell lines: cytokine profile and suppression of T cell lines reactive against myelin basic protein

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900379-4

7 January 2021

Human and murine CD4 T cell reactivity to a complex antigen: recognition of the synthetic random polypeptide glatiramer acetate

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900379-4

7 January 2021

Glatiramer acetate (Copaxone) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900379-4

7 January 2021

Direct binding of myelin basic protein and synthetic copolymer 1 to class II major histocompatibility complex molecules on living antigen-presenting cells--specificity and promiscuity.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900379-4

7 January 2021

Mechanisms of immunomodulation by glatiramer acetate

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900379-4

7 January 2021

Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900379-4

7 January 2021

Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years. Copolymer 1 Multiple Sclerosis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900379-4

7 January 2021

Interleukin-13 is produced by activated human CD45RA+ and CD45RO+ T cells: modulation by interleukin-4 and interleukin-12.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900379-4

7 January 2021

Coordinate regulation of the IL-4, IL-13, and IL-5 cytokine cluster in Th2 clones revealed by allelic expression patterns

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900379-4

7 January 2021

Treatment of multiple sclerosis with copolymer-1 (Copaxone): implicating mechanisms of Th1 to Th2/Th3 immune-deviation.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900379-4

7 January 2021

Selective loss of the suppressor-inducer T-cell subset in progressive multiple sclerosis. Analysis with anti-2H4 monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900379-4

7 January 2021

Multiple sclerosis: comparison of copolymer-1- reactive T cell lines from treated and untreated subjects reveals cytokine shift from T helper 1 to T helper 2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900379-4

7 January 2021

Copolymer-1-induced inhibition of antigen-specific T cell activation: interference with antigen presentation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900379-4

7 January 2021

Monoclonal antibodies to common epitopes of the human alpha/beta T-cell receptor preferentially activate CD45RA+ T-cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900379-4

7 January 2021

Suppression of experimental allergic encephalomyelitis by a synthetic polypeptide

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900379-4

7 January 2021

Oral tolerance with copolymer 1 for the treatment of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900379-4

7 January 2021

Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900379-4

7 January 2021

Lymphadenopathy in patients with multiple sclerosis undergoing treatment with glatiramer acetate

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900379-4

7 January 2021

Isolation and characterization of a human interleukin cDNA clone, homologous to mouse B-cell stimulatory factor 1, that expresses B-cell- and T-cell-stimulating activities

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900379-4

7 January 2021

Copolymer 1 inhibits experimental autoimmune uveoretinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900379-4

7 January 2021

10.1016/S0165-5728(01)00379-4

Identifiers

DOI

1 reference

26 November 2017

1 reference